223 related articles for article (PubMed ID: 22095072)
1. Tocotrienol as a potential anticancer agent.
Ling MT; Luk SU; Al-Ejeh F; Khanna KK
Carcinogenesis; 2012 Feb; 33(2):233-9. PubMed ID: 22095072
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic and anticancer potential of unsaturated vitamin E (tocotrienol).
Miyazawa T; Shibata A; Sookwong P; Kawakami Y; Eitsuka T; Asai A; Oikawa S; Nakagawa K
J Nutr Biochem; 2009 Feb; 20(2):79-86. PubMed ID: 19071006
[TBL] [Abstract][Full Text] [Related]
3. Multitargeted therapy of cancer by tocotrienols.
Nesaretnam K
Cancer Lett; 2008 Oct; 269(2):388-95. PubMed ID: 18504069
[TBL] [Abstract][Full Text] [Related]
4. Redox-inactive analogue of tocotrienol as a potential anti-cancer agent.
Yano T; Sato A; Sekine M; Virgona N; Ota M
Anticancer Agents Med Chem; 2013 Mar; 13(3):496-501. PubMed ID: 22721395
[TBL] [Abstract][Full Text] [Related]
5. Potential role of tocotrienols in the treatment and prevention of breast cancer.
Sylvester PW; Akl MR; Malaviya A; Parajuli P; Ananthula S; Tiwari RV; Ayoub NM
Biofactors; 2014; 40(1):49-58. PubMed ID: 23804535
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of tocotrienols: the mechanism of antiproliferative effects.
Wada S
Forum Nutr; 2009; 61():204-216. PubMed ID: 19367124
[TBL] [Abstract][Full Text] [Related]
7. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
Park SK; Sanders BG; Kline K
Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
[TBL] [Abstract][Full Text] [Related]
8. Tocotrienol research: past into present.
Wong RS; Radhakrishnan AK
Nutr Rev; 2012 Sep; 70(9):483-90. PubMed ID: 22946849
[TBL] [Abstract][Full Text] [Related]
9. Cytoprotective effects of vitamin E homologues against glutamate-induced cell death in immature primary cortical neuron cultures: Tocopherols and tocotrienols exert similar effects by antioxidant function.
Saito Y; Nishio K; Akazawa YO; Yamanaka K; Miyama A; Yoshida Y; Noguchi N; Niki E
Free Radic Biol Med; 2010 Nov; 49(10):1542-9. PubMed ID: 20736061
[TBL] [Abstract][Full Text] [Related]
10. Tocotrienol and cancer metastasis.
De Silva L; Chuah LH; Meganathan P; Fu JY
Biofactors; 2016; 42(2):149-62. PubMed ID: 26948691
[TBL] [Abstract][Full Text] [Related]
11. Tocotrienol inhibits secretion of angiogenic factors from human colorectal adenocarcinoma cells by suppressing hypoxia-inducible factor-1alpha.
Shibata A; Nakagawa K; Sookwong P; Tsuduki T; Tomita S; Shirakawa H; Komai M; Miyazawa T
J Nutr; 2008 Nov; 138(11):2136-42. PubMed ID: 18936210
[TBL] [Abstract][Full Text] [Related]
12. Synergistic Anticancer Effect of Tocotrienol Combined with Chemotherapeutic Agents or Dietary Components: A Review.
Eitsuka T; Tatewaki N; Nishida H; Nakagawa K; Miyazawa T
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669218
[TBL] [Abstract][Full Text] [Related]
13. Palm tocotrienols inhibit proliferation of murine mammary cancer cells and induce expression of interleukin-24 mRNA.
Selvaduray KR; Radhakrishnan AK; Kutty MK; Nesaretnam K
J Interferon Cytokine Res; 2010 Dec; 30(12):909-16. PubMed ID: 21121862
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytotoxicity in human lung adenocarcinoma cells by 6-O-carboxypropyl-alpha-tocotrienol, a redox-silent derivative of alpha-tocotrienol.
Yano Y; Satoh H; Fukumoto K; Kumadaki I; Ichikawa T; Yamada K; Hagiwara K; Yano T
Int J Cancer; 2005 Jul; 115(5):839-46. PubMed ID: 15723336
[TBL] [Abstract][Full Text] [Related]
15. Tocotrienols potentiate lovastatin-mediated growth suppression in vitro and in vivo.
McAnally JA; Gupta J; Sodhani S; Bravo L; Mo H
Exp Biol Med (Maywood); 2007 Apr; 232(4):523-31. PubMed ID: 17392488
[TBL] [Abstract][Full Text] [Related]
16. Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas.
Steuber N; Vo K; Wadhwa R; Birch J; Iacoban P; Chavez P; Elbayoumi TA
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792193
[TBL] [Abstract][Full Text] [Related]
17. A redox-silent analogue of tocotrienol acts as a potential cytotoxic agent against human mesothelioma cells.
Kashiwagi K; Virgona N; Harada K; Kido W; Yano Y; Ando A; Hagiwara K; Yano T
Life Sci; 2009 May; 84(19-20):650-6. PubMed ID: 19232361
[TBL] [Abstract][Full Text] [Related]
18. Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway.
Shin-Kang S; Ramsauer VP; Lightner J; Chakraborty K; Stone W; Campbell S; Reddy SA; Krishnan K
Free Radic Biol Med; 2011 Sep; 51(6):1164-74. PubMed ID: 21723941
[TBL] [Abstract][Full Text] [Related]
19. Hormones, vitamins, and growth factors in cancer treatment and prevention. A critical appraisal.
Lupulescu AP
Cancer; 1996 Dec; 78(11):2264-80. PubMed ID: 8940995
[TBL] [Abstract][Full Text] [Related]
20. Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens FL; Gerner EW
Clin Cancer Res; 1999 May; 5(5):945-51. PubMed ID: 10353725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
